1st Pharmaron Symposium in DMPK and Biology Was Held on May 30, 2015
BEIJING – May 30, 2015. Pharmaron held the 1st Pharmaron Symposium in DMPK & Biology. DMPK and biology are two critical components for drug discovery and development. This First International Symposium aimed to bring together highly sought–after speakers from all over the world to speak at Pharmaron Beijing. At this significant event, leaders from both academia and biopharmaceutical industry presented advances that showcase how DMPK and biology have interacted with each other, which, in turn, has fundamentally reshaped the modern drug R&D process. The Symposium also served as a training platform to strengthen Pharmaron’s integrated R&D abilities, gained additional insight about the development of the industry, and deepened understanding of DMPK and Biology.
Featured Speakers
Dr. Jonathan Huw Connick
Executive Director, Research Science at Merck
University of California, Berkeley,
USA and MSD China
Dr. David C. Evans
Vice President, Head Global Pharmacokinetics, Dynamics & Metabloism, Janssen R&D, Johnson & Johnson
USA
Dr. Vincent Jaquet
University of Geneva, Rue de Fribourg 5, 1201 Geneve
Switzerland
Dr. Barry C. Jones
Senior Principal Scientist, DMPK, Astrazeneca
UK
Dr. Yue Ma
Institute of Biophysics, Chinese Academy of Sciences
China
Prof. Jufeng Wang
Director National Center for Safety Evaluation of Drugs, National Institutes for food and Drug Control
China